Results 251 to 260 of about 111,421 (336)

A promising frontier of circulating messenger RNA in liquid biopsy: From mechanisms to clinical applications

International Journal of Cancer, Volume 157, Issue 8, Page 1519-1537, 15 October 2025.
Abstract Liquid biopsy can revolutionize cancer patient management as repeated sampling allows real‐time monitoring of disease progression and response to treatment. The circulating transcriptome represents a rich source of potential cancer biomarkers, including coding and non‐coding RNAs.
Mengqian Li, Yijin Yu, Guangyue Liu, Shunhong Zhang, Chenchen Luo, Saidi Hu, Siran Wan, Linyong Zhao   +7 more
wiley   +1 more source

Unraveling the pathogenesis of Barrett's esophagus and esophageal adenocarcinoma: the "omics" era. [PDF]

Front Oncol
Barchi A, Dell'Anna G, Massimino L, Mandarino FV, Vespa E, Viale E, Passaretti S, Annese V, Malesci A, Danese S, Ungaro F.   +10 more
europepmc   +1 more source

Esophageal metaplasia to adenocarcinoma: A population-based natural history

, 2003
Douglas A. Corley, Theodore R. Levin, Laurel A. Habel, Patricia A. Buffler   +3 more
openalex   +1 more source

Hsa_circRNA_0101125 Promotes Proliferation, Migration, and Invasion of Esophageal Squamous Cell Carcinoma via miR‐143‐3p/ZNF148 Axis

The FASEB Journal, Volume 39, Issue 19, 15 October 2025.
hsa_circRNA_0101125 promotes esophageal squamous cell carcinoma progression by sponging miR‐143‐3p and upregulating ZNF148 expression. This regulatory axis enhances tumor cell proliferation, migration, and invasion, likely by modulating EMT‐related markers including E‐cadherin and Vimentin.
Hao Chen, Songtao Xue, Shiqiang Cao, Jiarong Zhang, Yuanpu Wei, Chun Chen, Guobing Xu   +6 more
wiley   +1 more source

Patient-derived esophageal adenocarcinoma organ chip: a physiologically relevant platform for functional precision oncology [PDF]

J Transl Med
Pal S, Shimshoni E, Torres SF, Kong M, Tai K, Sangwan V, Bertos N, Bérubé J, Bailey SD, Ingber DE, Ferri L.   +10 more
europepmc   +2 more sources

Esophageal adenocarcinoma models: a closer look. [PDF]

Front Mol Biosci
Bhat N, Al-Mathkour M, Maacha S, Lu H, El-Rifai W, Ballout F.   +5 more
europepmc   +1 more source

Potential cost-effectiveness of aspirin (ASA) chemoprevention against esophageal adenocarcinoma (EAC) and colorectal cancer (CRC) in patients with Barrett's esophagus (BE)

, 2003
Uri Ladabaum, Douglas A. Corley, Jeffrey Fox, Prateek Shama   +3 more
openalex   +1 more source

ShcD adaptor protein drives invasion of triple negative breast cancer cells by aberrant activation of EGFR signaling

Molecular Oncology, Volume 19, Issue 10, Page 2833-2859, October 2025.
We identified adaptor protein ShcD as upregulated in triple‐negative breast cancer and found its expression to be correlated with reduced patient survival and increased invasion in cell models. Using a proteomic screen, we identified novel ShcD binding partners involved in EGFR signaling pathways.
Hayley R. Lau, Hayley S. Smith, Begüm Alural, Claire E. Martin, Laura A. New, Manali Tilak, Sara L. Banerjee, Hannah N. Robeson, Nicolas Bisson, Anne‐Claude Gingras, Jasmin Lalonde, Nina Jones   +11 more
wiley   +1 more source

Adenocarcinomas of the gastro-esophageal junction: A comparative study of the gastric cardia and the esophagus with respect to cyclooxygenase-2 expression

, 2003
Christianne J. Buskens, Anna Sivula, Marinke Westerterp, Johan Offerhaus, Ari Ristimäki, Jan van Lanschot   +5 more
openalex   +1 more source

Intersection Between Local Anesthetics and Cancer Biology: What Now? Where Are We Going?

Advanced Biology, Volume 9, Issue 10, October 2025.
Local anesthetics (LAs), widely used in anesthesia, may also play a role in cancer treatment by inhibiting tumor growth, reducing metastasis, and enhancing immune responses. They modulate key pathways like AKT/mTOR and RAS/ERK while affecting angiogenesis and tumor innervation and the immune response.
Eduardo Nunez‐Rodriguez, Hao Zhang, Dhananjay Sah, Juan P. Cata   +3 more
wiley   +1 more source